Search

Your search keyword '"Chartier, Loic"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Chartier, Loic" Remove constraint Author: "Chartier, Loic"
42 results on '"Chartier, Loic"'

Search Results

1. Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

2. Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis

3. A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma

4. Step-index optical fibre drawn from 3D printed preforms

5. A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort

6. Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial

8. Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA

9. Central nervous system relapse in younger patients with diffuse large B-cell lymphoma - a LYSA and GLA/ DSHNHL analysis

10. Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells

12. Essais cliniques et e-santé : impact des nouvelles technologies d’informations appliquées aux essais cliniques (y compris pour les données sources - dossier médical) et à la recherche sur la personne et le médicament

13. Clinical Trials and E-Health: Impact of New Information Technology Applied to Clinical Trials (Including Source Data-Medical Records) and to Human and Drug Research

14. Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA

16. Comparison of prognostic 18F-FDG PET metrics characterizing the dissemination of the disease in DLBCL patients

17. CNS relapse in DLBCL patients below 60 years treated with R-ACVBP, R-CHOEP, or R-CHOP: A joint analysis of LYSA and GLA/DSHNHL.

18. Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA

19. Evaluation of the Roche Cobas TaqMan and Abbott realtime extraction-quantification system for HIV-1 subtypes

20. High total metabolic tumor volume at baseline predicts survival independent of response to therapy

23. The Combination of High Total Metabolic Tumor Volume and Poor ECOG Performance Status Defines Ultra-High Risk Diffuse Large B-Cell Lymphoma. Validation across Multiple Cohorts of Large Clinical Trials and in Real World

26. Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma

27. First Line Therapy Evaluation Using Propensity Score Approach in Newly Diagnosed Advanced Classical Hodgkin Lymphoma Patients from Prospective Real-World Realysa Cohort and Phase 3 AHL2011 Trial

28. Impact of Total Metabolic Tumor Volume at Baseline in the Remarc Study

30. Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B

32. Hepatitis B Virus Exposure During Childhood in Cameroon, Central African Republic and Senegal After the Integration of HBV Vaccine in the Expanded Program on Immunization

37. Predictors of Pneumocystosis or Tuberculosis in HIV-Infected Asian Patients With AFB Smear-Negative Sputum Pneumonia

39. Low Suvmax Measured on Baseline FDG-PET/CT and Elevated beta 2 Microglobulin Are Negative Predictors of Outcome in High Tumor Burden Follicular Lymphoma Treated By Immunochemotherapy: A Pooled Analysis of Three Prospective Studies

41. Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells.

42. Predictors of pneumocystosis or tuberculosis in HIV-infected Asian patients with AFB smear-negative sputum pneumonia.

Catalog

Books, media, physical & digital resources